REGULATED PRESS RELEASE published on 02/10/2026 at 18:00, 11 days 20 hours ago CIS remporte plusieurs contrats stratégiques en Afrique, en Amérique du Sud et en Asie Le Groupe CIS remporte des contrats en Afrique, en Amérique du Sud et en Asie renforçant sa présence sur ses marchés historiques et confirmant la confiance de ses clients. Contrats incluent catering, housekeeping, facility management dans des environnements extrêmes CIS Asie Afrique Amérique Du Sud Contrats Stratégiques
REGULATED PRESS RELEASE published on 02/10/2026 at 18:00, 11 days 20 hours ago CIS wins several strategic contracts in Africa, South America and Asia CIS Group secures strategic contracts in Africa, South America, and Asia, enhancing presence in key markets. Contracts valued at $53 million align with international growth strategy South America Africa Asia CIS Group Strategic Contracts
PRESS RELEASE published on 02/10/2026 at 18:00, 11 days 20 hours ago FIN DE LA LIGNE DE FINANCEMENT (" EQUITY LINE ") Kalray annonce la fin de sa ligne de financement equity line avec IRIS ainsi que le remboursement des ORA restantes. La société ne prévoit pas de nouveau dispositif similaire. Prochains résultats annuels le 23 avril 2026 Financement Résultats Annuels Kalray ORA Equity Line
PRESS RELEASE published on 02/10/2026 at 18:00, 11 days 20 hours ago TERMINATION OF THE EQUITY LINE Kalray terminates equity line with IRIS after raising €6 million with bonds redeemable in new shares. No plans for new financing. Next press release: FY 2025 results on April 23, 2026 Financing IRIS Kalray Equity Line FY 2025 Results
PRESS RELEASE published on 02/10/2026 at 18:00, 11 days 20 hours ago RACHAT D'ACTIONS PROPRES Roche Bobois SA annonce des transactions dans le cadre de son programme de rachat d'actions propres autorisé par l'assemblée générale Rachat D'actions Transactions Euronext Programme Roche Bobois SA
PRESS RELEASE published on 02/10/2026 at 18:00, 11 days 20 hours ago THX Pharma and Biocodex announce a strategic licensing agreement covering three rare diseases Biocodex acquires licenses from THX Pharma to develop Batten-1 globally and TX01 in US and Canada. Deal worth up to €173M includes milestone payments and double-digit royalties Batten-1 Licenses TX01 THX Pharma Biocodex
PRESS RELEASE published on 02/10/2026 at 18:00, 11 days 20 hours ago THX Pharma et Biocodex annoncent un accord stratégique de licences dans trois maladies rares Biocodex acquiert les licences mondiales de Batten-1 et de TX01 pour le traitement de maladies rares en collaboration avec THX Pharma. Accord stratégique pour le développement et la commercialisation Maladies Rares Batten-1 TX01 THX Pharma Biocodex
PRESS RELEASE published on 02/10/2026 at 18:00, 11 days 20 hours ago U10 Corp - Bilan annuel du contrat de liquidité au 31 décembre 2025 Communiqué sur le bilan annuel du contrat de liquidité de U10 Corp avec TP ICAP, régulé par l'ACPR et l'AMF Contrat De Liquidité TP ICAP Bourse Finances U10 Corp
PRESS RELEASE published on 02/10/2026 at 17:57, 11 days 20 hours ago POS-Transaction in Own Shares Funding Circle Holdings plc purchases 52,389 Ordinary Shares from Investec Bank plc as part of its buy-back program London Stock Exchange Buy-back Program Own Shares Funding Circle Holdings PLC Investec Bank Plc
PRESS RELEASE published on 02/10/2026 at 17:52, 11 days 20 hours ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital TotalEnergies SE divulgue les informations sur le nombre d'actions et de droits de vote au 31 janvier 2026, conformément aux dispositions réglementaires Droits De Vote Capital Social Actions AMF TotalEnergies SE
Published on 02/21/2026 at 00:45, 1 day 13 hours ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 day 13 hours ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 1 day 15 hours ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 day 15 hours ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/22/2026 at 12:19, 1 hour 43 minutes ago Elmos Semiconductor SE: Generational change initiated in the Supervisory Board
Published on 02/22/2026 at 10:09, 3 hours 53 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 02/21/2026 at 12:00, 1 day 2 hours ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 1 day 2 hours ago Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 18:36, 1 day 19 hours ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 19:29, 1 day 18 hours ago SFPI GROUP: bilan du contrat de liquidité S2 S025